Publications
5674 Results
- Journal / Conference
- Cancer Treat Rep 69(5):557-558
- Year
- 1985
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-7931
Phase II study of amsacrine in gastric carcinoma: A Southwest Oncology Group study.
- Journal / Conference
- Cancer Treat Rep 69:709-710
- Year
- 1985
- Research Committee(s)
- Genitourinary
Phase II trial of diaziquone in advanced large bowel carcinoma in previously treated and untreated patients: A Southwest Oncology Group study.
- Journal / Conference
- Urology 25(3):248-250
- Year
- 1985
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-7956
Infarction - nephrectomy for metastatic renal carcinoma. A Southwest Oncology Group study.
- Journal / Conference
- Cancer Treat Rep 69:231-233
- Year
- 1985
- Research Committee(s)
- Sarcoma
- Study Number(s)
- SWOG-8004
Phase II trial of mitoxantrone in advanced sarcomas: A Southwest Oncology Group study.
- Journal / Conference
- Cancer Treat Rep 69(11):1313-1314
- Year
- 1985
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8012
Phase II trial of 5-fluorouracil, vincristine, and mitomycin-C (FOMi) in metastatic bronchioalveolar cell lung cancer. A Southwest Oncology Group study.
- Journal / Conference
- Cancer Treat Rep 69(11):1329-1330
- Year
- 1985
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8028
Mitoxantrone in adenocarcinoma of the endometrium: A Southwest Oncology Group study.
- Journal / Conference
- Cancer Treat Rep 69(11):1321-1323
- Year
- 1985
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8031
Phase II trial of mitoxantrone in multiple myeloma: A Southwest Oncology Group study.
- Journal / Conference
- Cytometry 6:357-361
- Year
- 1985
- Research Committee(s)
- Breast
Short-term cryopreservation of human breast carcinoma cells for flow cytometry.
- Journal / Conference
- Invest New Drugs 3:67-69
- Year
- 1985
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8065
Phase II trial of 1,4-dihydorxy-5, 8-bis((2-((2-hydroxyethyl) amino) ethyl) amino 9,10-anthracenedione dihydrochloride) (NSC 301739, DHAD) in patients with metastatic malignant melanoma.
- Journal / Conference
- Cancer Treat Rep 69:129-131
- Year
- 1985
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8066